XML 19 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Oct. 31, 2021
Oct. 31, 2020
Revenues:        
Total revenues $ 6,863 $ 5,419 $ 19,166 $ 15,435
Cost of revenues:        
Total cost of revenues [1],[2] 1,844 1,394 5,012 3,959
Gross profit 5,019 4,025 14,154 11,476
Operating expenses:        
Research and development [1],[2] 1,203 902 3,174 2,659
Marketing and sales [1],[2] 3,111 2,377 8,391 7,042
General and administrative [1],[2] 667 522 1,865 1,513
Total operating expenses [1],[2] 4,981 3,801 13,430 11,214
Income from operations 38 224 724 262
Gains on strategic investments, net 363 1,036 1,177 1,910
Other expense (102) (10) (172) (36)
Income before benefit from (provision for) income taxes 299 1,250 1,729 2,136
Benefit from (provision for) income taxes [3] 169 (169) (257) 1,669
Net income $ 468 $ 1,081 $ 1,472 $ 3,805
Basic net income per share (in dollars per share) $ 0.48 $ 1.19 $ 1.56 $ 4.20
Diluted net income per share (in dollars per share) $ 0.47 $ 1.15 $ 1.53 $ 4.11
Shares used in computing basic net income per share (in shares) 980 911 945 905
Shares used in computing diluted net income per share (in shares) 1,001 939 964 926
Subscription and support        
Revenues:        
Total revenues $ 6,379 $ 5,085 $ 17,829 $ 14,500
Cost of revenues:        
Total cost of revenues [1],[2] 1,335 1,060 3,603 3,039
Professional services and other        
Revenues:        
Total revenues 484 334 1,337 935
Cost of revenues:        
Total cost of revenues [1],[2] $ 509 $ 334 $ 1,409 $ 920
[1] Amounts include amortization of intangible assets acquired through business combinations, as follows:
 Three Months Ended October 31,Nine Months Ended October 31,
 2021202020212020
Cost of revenues$272 $169 $624 $494 
Marketing and sales236 114 491 344 
[2] Amounts include stock-based expense, as follows:
 Three Months Ended October 31,Nine Months Ended October 31,
 2021202020212020
Cost of revenues$103 $65 $280 $180 
Research and development276 181 646 531 
Marketing and sales316 242 817 718 
General and administrative117 78 273 219 
[3] During the second quarter of fiscal 2021, the Company recorded approximately $2.0 billion of a one-time benefit from a discrete tax item related to the recognition of deferred tax assets resulting from an intra-entity transfer of intangible property.